Evidence has shown that the expression of RAB3D is upregulated by the ceRNA mechanism in non-small cell lung cancer, osteosarcoma, renal cell carcinoma, and melanoma, leading to tumor progression [28–32]. Here, RAB3D is linked to renal cell carcinoma.